第一作者:
Michael J A,Reid
第一单位:
Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: michael.reid2@ucsf.edu.
作者:
Michael J A,Reid [1]
;
Nimalan,Arinaminpathy [2]
;
Amy,Bloom [3]
;
Barry R,Bloom [4]
;
Catharina,Boehme [5]
;
Richard,Chaisson [6]
;
Daniel P,Chin [7]
;
Gavin,Churchyard [8]
;
Helen,Cox [9]
;
Lucica,Ditiu [10]
;
Mark,Dybul [11]
;
Jeremy,Farrar [12]
;
Anthony S,Fauci [13]
;
Endalkachew,Fekadu [14]
;
Paula I,Fujiwara [15]
;
Timothy B,Hallett [2]
;
Christy L,Hanson [7]
;
Mark,Harrington [16]
;
Nick,Herbert [17]
;
Philip C,Hopewell [18]
;
Chieko,Ikeda [19]
;
Dean T,Jamison [20]
;
Aamir J,Khan [21]
;
Irene,Koek [22]
;
Nalini,Krishnan [23]
;
Aaron,Motsoaledi [24]
;
Madhukar,Pai [25]
;
Mario C,Raviglione [26]
;
Almaz,Sharman [27]
;
Peter M,Small [28]
;
Soumya,Swaminathan [29]
;
Zelalem,Temesgen [30]
;
Anna,Vassall [31]
;
Nandita,Venkatesan [32]
;
Kitty,van Weezenbeek [33]
;
Gavin,Yamey [34]
;
Bruce D,Agins [35]
;
Sofia,Alexandru [36]
;
Jason R,Andrews [37]
;
Naomi,Beyeler [38]
;
Stela,Bivol [39]
;
Grania,Brigden [15]
;
Adithya,Cattamanchi [18]
;
Danielle,Cazabon [40]
;
Valeriu,Crudu [39]
;
Amrita,Daftary [25]
;
Puneet,Dewan [41]
;
Laurie K,Doepel [13]
;
Robert W,Eisinger [13]
;
Victoria,Fan [42]
;
Sara,Fewer [38]
;
Jennifer,Furin [43]
;
Jeremy D,Goldhaber-Fiebert [44]
;
Gabriela B,Gomez [45]
;
Stephen M,Graham [46]
;
Devesh,Gupta [47]
;
Maureen,Kamene [48]
;
Sunil,Khaparde [49]
;
Eunice W,Mailu [48]
;
Enos O,Masini [50]
;
Lorrie,McHugh [51]
;
Ellen,Mitchell [52]
;
Suerie,Moon [53]
;
Michael,Osberg [54]
;
Tripti,Pande [40]
;
Lea,Prince [44]
;
Kirankumar,Rade [55]
;
Raghuram,Rao [56]
;
Michelle,Remme [57]
;
James A,Seddon [58]
;
Casey,Selwyn [7]
;
Priya,Shete [18]
;
Kuldeep S,Sachdeva [47]
;
Guy,Stallworthy [59]
;
Juan F,Vesga [2]
;
Valentina,Vilc [60]
;
Eric P,Goosby [61]
作者单位:
Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: michael.reid2@ucsf.edu.
[1]
School of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK.
[2]
Tuberculosis Division, United States Agency for International Development, Washington, DC, USA.
[3]
Department of Global Health and Population, Harvard University, Cambridge, MA, USA.
[4]
Foundation for Innovative New Diagnostics, Geneva, Switzerland.
[5]
Departments of Medicine, Epidemiology, and International Health, Johns Hopkins School of Medicine, Baltimore, MA, USA.
[6]
Bill & Melinda Gates Foundation, Seattle, WA, USA.
[7]
The Aurum Institute, Johannesburg, South Africa.
[8]
Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
[9]
Stop TB Partnership, Geneva, Switzerland.
[10]
Department of Medicine, Centre for Global Health and Quality, Georgetown University, Washington, DC, USA.
[11]
The Wellcome Trust, London, UK.
[12]
National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA.
[13]
Volunteer Health Services, Addis Ababa, Ethiopia.
[14]
Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France.
[15]
Treatment Action Group, New York, NY, USA.
[16]
Global TB Caucus, Houses of Parliament, London, UK.
[17]
Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
[18]
Department of GLobal Health, Ministry of Heath, Labor and Welfare, Tokyo, Japan.
[19]
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
[20]
Interactive Research & Development, Karachi, Pakistan.
[21]
Global Health Bureau, United States Agency for International Development, Washington, DC, USA.
[22]
Resource Group for Education and Advocacy for Community Health, Chennai, India.
[23]
South African National Department of Health, Pretoria, South Africa.
[24]
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada.
[25]
University of Milan, Milan, Italy; Global Studies Institute, University of Geneva, Geneva, Switzerland.
[26]
Academy of Preventive Medicine of Kazakhstan, Almaty, Kazakhstan.
[27]
Global Health Institute, School of Medicine, Stony Brook University, Stony Brook, NY, USA.
[28]
WHO, Geneva, Switzerland.
[29]
Department of Infectious Diseases, Mayo Clinic, Rochester, MI, USA.
[30]
Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK; Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands.
[31]
The Economic Times, Mumbai, India.
[32]
KNCV Tuberculosis Foundation, The Haag, Netherlands.
[33]
Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA.
[34]
Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
[35]
Institutul de Ftiziopneumologie Chiril Draganiuc, Chisinau, Moldova.
[36]
Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA.
[37]
Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
[38]
Center for Health Policies and Studies, Chisinau, Moldova.
[39]
McGill International TB Center, McGill University, Montreal, QC, Canada.
[40]
Bill & Melinda Gates Foundation, New Delhi, India.
[41]
T H Chan School of Public Health, Harvard University, Cambridge, MA, USA; Office of Public Health Studies, University of Hawaii, Mānoa, HI, USA.
[42]
Division of Infectious Diseases & HIV Medicine, Case Western Reserve University, Cleveland, OH, USA.
[43]
Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA.
[44]
Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
[45]
Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Paediatrics, Center for International Child Health, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia.
[46]
Revised National TB Control Program, New Delhi, India.
[47]
National Tuberculosis, Leprosy and Lung Disease Program, Ministry of Health, Nairobi, Kenya.
[48]
General TB control, New Delhi, India.
[49]
WHO, Nairobi, Kenya.
[50]
Office of the Secretary-General's Special Envoy on Tuberculosis, United Nations, Geneva, Switzerland.
[51]
International Institute of Social Studies, Erasmus University Rotterdam, The Hague, Netherland.
[52]
Department of Global Health and Population, Harvard University, Cambridge, MA, USA; Global Health Centre, The Graduate Institute Geneva, Geneva, Switzerland.
[53]
Linksbridge, Seattle, WA, USA.
[54]
Central Tuberculosis Division, WHO, New Delhi, India.
[55]
Ministry of Health and Family Welfare, New Delhi, India.
[56]
International Institute for Global Health, United Nations University, Kuala Lumpur, Malaysia.
[57]
Department of Medicine, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK; Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa.
[58]
Seattle, WA, USA.
[59]
National TB Program, WHO, Chisinau, Moldova.
[60]
Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
[61]
医学主题词
患病代价(Cost of Illness);目的(Goals);卫生政策(Health Policy);卫生工作重点(Health Priorities);人类(Humans);发病率(Incidence);领导(Leadership);死亡率(Mortality);结核分枝杆菌(Mycobacterium tuberculosis);政治制度(Political Systems);卫生保健质量(Quality of Health Care);研究(Research);结核, 肺(Tuberculosis, Pulmonary);世界卫生组织(World Health Organization)
DOI
10.1016/S0140-6736(19)30024-8
PMID
30904263
发布时间
2021-08-03
- 浏览28
Lancet (London, England)
Lancet (London, England)
1331-1384页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文





换一批



